Stay updated on PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial
Sign up to get notified when there's something new on the PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial page.

Latest updates to the PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial page
- Check6 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2. No substantive study details or user-facing content appear to be changed.SummaryDifference0.0%

- Check13 days agoChange DetectedPublications note updated to indicate items are automatically filled from PubMed and may not relate to the study; page revision updated to v3.3.1.SummaryDifference0.1%

- Check21 days agoChange DetectedA government funding status notice was removed from the page. The study details themselves appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check35 days agoChange DetectedTwo screenshots show only minor UI/formatting differences with no changes to study details, eligibility criteria, or interventions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check64 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%

- Check71 days agoChange DetectedUpdate to version from v3.0.2 to v3.1.0, indicating a new release; no other content changes detected.SummaryDifference0.1%

Stay in the know with updates to PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial page.